These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 23957795)

  • 1. A review of treatment and management modalities for premenstrual dysphoric disorder.
    Kelderhouse K; Taylor JS
    Nurs Womens Health; 2013; 17(4):294-305. PubMed ID: 23957795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and management of premenstrual syndrome and premenstrual dysphoric disorder.
    Frackiewicz EJ; Shiovitz TM
    J Am Pharm Assoc (Wash); 2001; 41(3):437-47. PubMed ID: 11372908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premenstrual dysphoric disorder--review of actual findings about mental disorders related to menstrual cycle and possibilities of their therapy.
    Zukov I; Ptácek R; Raboch J; Domluvilová D; Kuzelová H; Fischer S; Kozelek P
    Prague Med Rep; 2010; 111(1):12-24. PubMed ID: 20359434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premenstrual syndrome: A mini review.
    Ryu A; Kim TH
    Maturitas; 2015 Dec; 82(4):436-40. PubMed ID: 26351143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management strategies for premenstrual syndrome/premenstrual dysphoric disorder.
    Jarvis CI; Lynch AM; Morin AK
    Ann Pharmacother; 2008 Jul; 42(7):967-78. PubMed ID: 18559957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of premenstrual symptom severity and impairment in Korean adolescents: premenstrual dysphoric disorder, subthreshold premenstrual dysphoric disorder and premenstrual syndrome.
    Yang J; Joe SH; Lee MS; Kim SH; Jung IK
    Asia Pac Psychiatry; 2014 Jun; 6(2):135-44. PubMed ID: 23857722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of PMDD and pre-menstrual syndrome on mood disorders and quality of life: a cross-sectional study.
    Balık G; Hocaoğlu Ç; Kağıtcı M; Güvenda Güven ES
    J Obstet Gynaecol; 2015; 35(6):616-20. PubMed ID: 25528894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis.
    Freeman EW
    Psychoneuroendocrinology; 2003 Aug; 28 Suppl 3():25-37. PubMed ID: 12892988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An overview of premenstrual syndrome].
    Zaafrane F; Faleh R; Melki W; Sakouhi M; Gaha L
    J Gynecol Obstet Biol Reprod (Paris); 2007 Nov; 36(7):642-52. PubMed ID: 17321695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of premenstrual syndromes and premenstrual dysphoric disorder: current practices.
    Mitwally MF; Kahn LS; Halbreich U
    Expert Opin Pharmacother; 2002 Nov; 3(11):1577-90. PubMed ID: 12437492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premenstrual dysphoric disorder. A guide for the treating clinician.
    Elliott H
    N C Med J; 2002; 63(2):72-5. PubMed ID: 12063908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A symptom diary to assess severe premenstrual syndrome and premenstrual dysphoric disorder.
    Janda C; Kues JN; Andersson G; Kleinstäuber M; Weise C
    Women Health; 2017 Aug; 57(7):837-854. PubMed ID: 27355449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The premenstrual syndrome].
    van der Leij F; Schultz WC; van de Wiel H; van Leeuwen JH
    Ned Tijdschr Geneeskd; 2010; 154():A1341. PubMed ID: 20719012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premenstrual syndrome and premenstrual dysphoric disorder in adolescents.
    Itriyeva K
    Curr Probl Pediatr Adolesc Health Care; 2022 May; 52(5):101187. PubMed ID: 35534402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD).
    Halbreich U; Borenstein J; Pearlstein T; Kahn LS
    Psychoneuroendocrinology; 2003 Aug; 28 Suppl 3():1-23. PubMed ID: 12892987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premenstrual syndrome and premenstrual dysphoric disorder: quality of life and burden of illness.
    Rapkin AJ; Winer SA
    Expert Rev Pharmacoecon Outcomes Res; 2009 Apr; 9(2):157-70. PubMed ID: 19402804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biopsychosocial aspects of premenstrual syndrome and premenstrual dysphoric disorder.
    Matsumoto T; Asakura H; Hayashi T
    Gynecol Endocrinol; 2013 Jan; 29(1):67-73. PubMed ID: 22809066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premenstrual dysphoric disorder and eating disorders.
    Verri A; Nappi RE; Vallero E; Galli C; Sances G; Martignoni E
    Cephalalgia; 1997 Dec; 17 Suppl 20():25-8. PubMed ID: 9496774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder.
    Freeman EW
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():27-34; discussion 42-3. PubMed ID: 12659404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Premenstrual syndrome and premenstrual dysphoric disorder].
    Kovács Z; Hegyi G; Szőke H
    Orv Hetil; 2022 Jun; 163(26):1023-1031. PubMed ID: 35895486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.